...
首页> 外文期刊>Journal of Medical Radiation Sciences >Identifying breast cancer patients who gain the most dosimetric benefit from deep inspiration breath hold radiotherapy
【24h】

Identifying breast cancer patients who gain the most dosimetric benefit from deep inspiration breath hold radiotherapy

机译:鉴定乳腺癌患者,这些患者从深度灵感呼吸持有放射治疗中获得最多剂量的益处

获取原文

摘要

Introduction Deep inspiration breath hold (DIBH) has been proven to reduce cardiac dose for women receiving left breast and chest wall radiation therapy. However, it utilises extra departmental resources and patient exertion. The aim of this exploratory study was to investigate if any factors existed that could identify breast cancer patients who may benefit most from DIBH, to facilitate appropriate utilisation of departmental resources. Methods Left‐sided breast cancer patients aged 18–70?years, and right‐sided breast cancer patients with internal mammary nodes included, were recruited. DIBH and free breathing (FB) plans were created for all patients. Patient demographic and clinical history were recorded. Variables including lung threshold value, lung volume, patient separation, maximum heart in field, volume of planning target volume (PTV), heart dose, ipsilateral lung dose were compared between plans. Results Plans for 31 patients were analysed. No correlations were found between lung threshold value or patient separation and cardiac dose. Moderate to strong correlations were found with BMI, PTV volume and lung volume change however no definitive thresholds were determined. A significant difference was found in the maximum heart in field between DIBH and FB (P??0.001) with those patients with greater than 0.7?cm heart in the field on the FB scan demonstrating greater reductions in mean heart dose. Conclusion Maximum heart in the field of greater than 0.7?cm in FB could be a potential factor to identify patients who may benefit most from DIBH. This factor warrants investigation in a larger patient cohort to test its validity.
机译:引言深度灵感呼吸暂停(DIBH)已被证明减少接受左乳房和胸壁放射治疗的女性的心脏剂量。但是,它利用额外的部门资源和患者劳累。该探索性研究的目的是调查是否存在可能识别可能从DIBH受益的乳腺癌患者的任何因素,以促进适当利用部门资源。方法征聘左侧乳腺癌患者18-70岁的乳腺癌患者和右侧乳腺癌患者包括内部乳房节点。为所有患者创造了Dibh和免费呼吸(FB)计划。记录患者人口统计和临床历史。变量包括肺部阈值,肺体积,患者分离,最大心脏在现场,规划靶体积(PTV)的体积,在计划之间比较了心脏剂量,心脏剂量,肺剂量。结果分析了31例患者的计划。在肺部阈值或患者分离和心脏剂量之间没有发现相关性。在BMI,PTV体积和肺体积变化中发现了中度至强的相关性,但没有确定明确的阈值。在FB扫描上的患者中,DIBH和FB(P≤0.001)的最大心脏中发现了显着的差异,这些患者在FB扫描上的患者展示了更大的心脏剂量减少。结论FB中大于0.7Ω厘米的最大心脏可能是识别可能从DIBH受益的患者的潜在因素。这个因素需要在更大的患者队列中进行调查以测试其有效性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号